Post by Breakthrough T1D

Name: Breakthrough T1D CEO Aaron Kowalski, Ph.D., sits down for a conversation with Katie Beth Hand, a par
Uploaded: 2026-03-10T16:00:38.465Z
Channel: Breakthrough T1D
Description: Breakthrough T1D CEO Aaron Kowalski, Ph.D., sits down for a conversation with Katie Beth Hand, a participant in the University of Chicago's clinical trial testing Eledon's tegoprubart. Tegoprubart i

56,679 followers

Breakthrough T1D CEO Aaron Kowalski, Ph.D., sits down for a conversation with Katie Beth Hand, a participant in the University of Chicago's clinical trial testing Eledon's tegoprubart. Tegoprubart is used as an alternative to standard immunosuppressants to help prevent transplanted islet cells from rejection in people with type 1 diabetes. Watch their full conversation about this exciting Breakthrough T1D-funded clinical trial here: https://lnkd.in/dVNV8_tv

Video Content